Nexomics Biosciences

Nexomics Biosciences is a specialized contract research organization (CRO) that provides integrated structural biology and protein science services to biopharma and biotech clients. Leveraging intellectual property from a large-scale structural genomics project, the company's mission is to give customers a competitive advantage in early-stage drug discovery by delivering high-quality protein products and high-resolution 3D structures. Operating as a private, revenue-generating services business, it focuses on the high-growth oncology and immunology sectors. Its model is built on deep scientific expertise in challenging protein targets and a broad technological toolkit spanning bioinformatics, NMR, X-ray crystallography, and Cryo-EM.

Integrated 'gene-to-structure' platform combining bioinformatics, challenging protein production, and multi-modal structural determination (X-ray crystallography, NMR spectroscopy, Cryo-EM), supported by biophysical analysis and software.

Nexomics competes in the specialized structural biology CRO segment. Key competitors range from large, diversified CROs (e.g., Charles River Laboratories, Evotec) with structural biology units to pure-play structural biology firms (e.g., Creative Biostructure, Proteos) and academic core facilities. Differentiation is based on scientific expertise, success with challenging targets, integrated service breadth, and technological capabilities in Cryo-EM and NMR.